๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)
Singapore flag Singapore ยท Delayed Price ยท Currency is SGD
0.0260
0.00 (0.00%)
At close: Nov 18, 2026

SGXC:9G2 Financials Overview

Millions SGD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
16.1115.7215.7116.6516.2313.81
Revenue Growth
1.85%0.05%-5.63%2.54%17.56%6.90%
Gross Profit
6.966.866.778.829.878.64
Operating Income
-18.99-19.69-21.7-20.73-13.83-13.32
Net Income
-23.24-23.9-27.05-37.45-18.07-12.43
Earnings Per Share
--0.02-0.03-0.05-0.03-0.02
EPS Growth
------

Revenue by Segment

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '25 Jun '24 Jun '23 Jun '22
Medical Diagnostics and Treatments
12.5212.5514.6715.4313.49
Radiation Therapy and Medical Oncology Services
3.193.161.970.80.32
Total
15.7215.7116.6516.2313.81

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
7.2415.43.383.2111.316.11
Total Debt
59.1261.2858.2146.180.7787.3
Net Cash (Debt)
-51.89-45.88-54.83-42.89-69.48-71.19
Net Cash Growth
------
Net Cash Per Share
--0.04-0.05-0.05-0.10-0.11

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-8.11-3.65-10.65-12.93-3.24-5.81
Capital Expenditures
-0.51-0.49-0.15-0.53-14.44-4.09
Free Cash Flow
-8.62-4.14-10.8-13.46-17.68-9.89
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
43.17%43.64%43.11%52.99%60.78%62.54%
Operating Margin
-117.87%-125.26%-138.15%-124.56%-85.17%-96.43%
Pretax Margin
-144.19%-151.97%-172.17%-224.91%-116.82%-104.85%
Profit Margin
-144.25%-152.04%-172.22%-224.95%-111.32%-89.98%
FCF Margin
-53.51%-26.31%-68.74%-80.88%-108.89%-71.66%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
2.783.291.966.36--